| Epicardial fat: More than an adipose tissue | Sanem Nalbantgil, Göksel Çinier | 427–429 |
| Epicardial fat tissue may predict new-onset atrial fibrillation in patients with non-ST-segment elevation myocardial infarction | Hayati Eren, Lütfi Öcal, Muhammed Bahadır Omar | 430–438 |
| Differences in autoimmunity factors based on the activity of thromboangiitis obliterans | Seyed Morteza Ehteshamfar, Abbas Shapouri-Moghadam, Seyed Jalil Tavakkol Afshari, Mohammad-Hadi Saeed Modaghegh, Mahmoud Mahmoudi, Hamid Reza Rahimi | 439–447 |
| Associations of F2 (G20210A), F5 (G1691A), F7 (G10976A), F13 (G13T), FGB, ITGA2, ITGB3, and PAI-I gene polymorphisms with cardiovascular and thrombotic complications in patients with Takayasu arteritis from the Urals population | Irina Borodina, Gezel Salavatova, Lubov Shardina | 448–455 |
| Characteristics of a large-scale cohort with accessory pathway(s): A cross-sectional retrospective study highlighting over a twenty-year experience | Erhan Bozkurt, Hasan Kutsi Kabul, Hatice Tolunay, Serdar Fırtına, Serkan Asil, Uygar Çağdaş Yüksel, Suat Görmel, Salim Yaşar, Erkan Yıldırım, Murat Çelik, Cem Barçın, Veysel Kutay Vurgun, Barış Buğan, Yalçın Gökoğlan, Basri Amasyalı, Sedat Köse | 456–462 |
| Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range | Selçuk Kanat, Taner Şen, Murat Gül, Habibe Kafes, Ahmet Temizhan, Lale Dinç Asarcıklı, Esra Gucuk İpek, Muhammet Cebeci | 463–473 |
| Ethical evaluation of informed consent forms used in the cardiology clinics and the importance of institutional standardized approach | Ufuk İyigün | 474–476 |
| Ethical evaluation of informed consent forms used in cardiology clinics and the importance of institutional standardized approach | Perihan Elif Ekmekçi, Müberra Devrim Güner, Aksüyek Savaş Çelebi | 477–487 |
| Recognizing electrocardiographically subtle occlusion myocardial infarction and differentiating it from mimics: Ten steps to or away from cath lab | Emre K. Aslanger, H. Pendell Meyers, Stephen W. Smith | 488–500 |
| Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction |